Publications by authors named "Ian Portek"

Claim this Profile
T
Therapeutic plasmapheresis as an effective treatment for refractory anti-3-hydroxy-3-methylglutaryl coenzyme A reductase-positive immune-mediated necrotising myopathy.
Andrea Lyon, Ian Portek, Matthew Parker, Vidya Limaye

BMJ Case Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.
Richard O Day, Lauren J Frensham, Amy D Nguyen, Melissa T Baysari, Eindra Aung, Ian Portek

BMJ Open· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualising the dose of allopurinol in patients with gout.
Diluk R W Kannangara, Garry G Graham, Daniel F B Wright, Sophie L Stocker, Ian Portek

Br J Clin Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.
Garry G Graham, Diluk R W Kannangara, Sophie L Stocker, Ian Portek, Kevin D Pile

Br J Clin Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinion.
Claire Barrett, Paul Bird, Gabor Major, Evange Romas, Ian Portek

Int J Rheum Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients.
Diluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, Sophie L Stocker, Garry G Graham, Ian Portek

Arthritis Res Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).
Bruce W Kirkham, Marissa N Lassere, John P Edmonds, Katherine M Juhasz, Paul A Bird, Ian J Portek

Arthritis Rheum· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Documenting damage progression in a two-year longitudinal study of rheumatoid arthritis patients with established disease (the DAMAGE study cohort): is there an advantage in the use of magnetic resonance imaging as compared with plain radiography?
Paul Bird, Bruce Kirkham, Ian Portek, Ron Shnier, Fredrick Joshua

Arthritis Rheum· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and reliability of arthroscopic estimates of cartilage lesion size in a plastic knee simulation model.
Stephen P Oakley, Ian Portek, Zoltan Szomor, Allen Turnbull, George A c Murrell

Arthroscopy· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis